Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease

Prior treatment

• Treatment with chronic or newly initiated home ventilatory support. Those on in-patient short-term non-invasive ventilation will not be excluded.

Other illness

• Other respiratory conditions that could confound the diagnosis such as asthma, pulmonary fibrosis, bronchiectasis, and lung cancer. Participants with pneumonic exacerbations of COPD will be included.
• Primary diagnosis of COVID pneumonia. Individuals with incidentally detected COVID or persistently positive for COVID but deemed to be convalescent will not be excluded.
• Active cancers on chemotherapy or radiation therapy
• Immunosuppressed states predisposing to frequent hospitalizations including uncontrolled HIV/AIDS
• Active or recent (within 1 month) myocardial infarction
• Angina not well-controlled by medication
• Unstable cardiac arrhythmias, atrial or ventricular
• Significant cognitive dysfunction, including dementia, that in opinion of investigator would impair ability to safely or effectively engage in study protocol
• Participants with any terminal medical illnesses as diagnosed by a physician, and/or on hospice

Lab values

• Secondary diagnosis of congestive heart failure that is severe as documented by active symptoms, New York Heart Association (NYHA) functional classification IV or left ventricular ejection fraction \<25% on echocardiography

Other

• Supplemental oxygen requirement greater than 5 liters per minute at either rest or with exertion
• Currently enrolled in and participating in pulmonary rehabilitation
• Special patient groups such as prisoners and institutionalized patients
• Participants with musculoskeletal comorbidities or physical infirmities that preclude participation in an exercise program
• Current participation in any other interventional clinical trial
• Inability to understand and speak English during exercise sessions
• Inability or unwillingness to comply with study and/or follow-up procedures outlined in the protocol

• Age 40 or greater
• Clinical diagnosis of COPD
• Hospitalized for acute exacerbation of COPD.
• Be willing to adhere to trial and follow-up procedures and give informed consent